Opportunities, Barriers, and a Strategy for Overcoming Translational Challenges to Therapeutic Nucleic Acid Nanotechnology-Reference-Cited by-同舟云学术

Opportunities, Barriers, and a Strategy for Overcoming Translational Challenges to Therapeutic Nucleic Acid Nanotechnology

Published:2020-07-24 Issue:8 Volume:14 Page:9221-9227
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Afonin Kirill A.¹^ORCID,Dobrovolskaia Marina A.²^ORCID,Church George³⁴⁵,Bathe Mark⁶^ORCID

Affiliation:

1. Nanoscale Science Program, Department of Chemistry, The University of North Carolina at Charlotte, Charlotte, North Carolina 28223, United States

2. Nanotechnology Characterization Lab, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland 21702, United States

3. Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, United States

4. Wyss Institute for Biologically Inspired Engineering, Boston, Massachusetts 02115, United States

5. Harvard Graduate Program in Biological and Biomedical Sciences, Boston, Massachusetts 02115, United States

6. Department of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States

Funder

DHHS Office of the Secretary

Army Research Office

Office of Naval Research Global

National Institutes of Health

National Institute of General Medical Sciences

National Science Foundation

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link